Journal article
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.
- Kühne T Division of Oncology/Hematology, University Children's Hospital, Basel, Switzerland. Thomas.Kuehne@hin.ch
- Buchanan GR
- Zimmerman S
- Michaels LA
- Kohan R
- Berchtold W
- Imbach P
- 2003-11-15
Published in:
- The Journal of pediatrics. - 2003
Adolescent
Age Distribution
Anti-Inflammatory Agents
Child
Female
Follow-Up Studies
Humans
Immunoglobulins, Intravenous
Incidence
Infant
Male
Prospective Studies
Purpura, Thrombocytopenic, Idiopathic
Surveys and Questionnaires
English
OBJECTIVE
To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP).
STUDY DESIGN
International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires.
RESULTS
Data from 2540 patients were analyzed, including 203 infants (7.6%), 1860 children > or =1 to <10 years of age (69.1%), and 477 children and adolescents between > or =10 and <16 years of age (17.7%). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20x10(9)/L. The male/female ratio was highest in infants and decreased with age (P=.009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients > or =10 years of age. Follow-up information at 6 months was available for 1742 children (68.6%). Chronic ITP was seen less frequently in infants (23.1%) than in children >10 years of age (47.3%, P<.0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP.
CONCLUSIONS
Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.
To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP).
STUDY DESIGN
International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires.
RESULTS
Data from 2540 patients were analyzed, including 203 infants (7.6%), 1860 children > or =1 to <10 years of age (69.1%), and 477 children and adolescents between > or =10 and <16 years of age (17.7%). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20x10(9)/L. The male/female ratio was highest in infants and decreased with age (P=.009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients > or =10 years of age. Follow-up information at 6 months was available for 1742 children (68.6%). Chronic ITP was seen less frequently in infants (23.1%) than in children >10 years of age (47.3%, P<.0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP.
CONCLUSIONS
Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1067/s0022-3476(03)00535-3
- PMID 14615730
- Persistent URL
- https://folia.unifr.ch/global/documents/205640
Statistics
Document views: 23
File downloads: